Shares of business process automation firm Exela Technologies (NASDAQ: XELA) are rallying premarket on Tuesday after the company announced a 10 year, $90 million venture blending automation technologies, SaaS, and services through its PCH Global platform.
The PCH Global platform officially launched in September last year. Exela’s strategy is to migrate existing and future healthcare customers to PCH Global’s cloud network to offer greater scalability and business continuity protections.
The company’s share price is up 37.5% premarket at $2.27 after closing Monday’s session down 4.6%.
Exela said the venture is the first of its kind for the company in the healthcare industry, as it involves the large-scale deployment of its digital exchange platform in the cloud and onsite to deliver healthcare solutions.
“The venture involves the end-to-end processing of complex health insurance claims and multi-channel correspondence between the insurance company and their provider and member networks,” the Texas-based company said.
Exela’s President, Suresh Yannamani, commented: “The combination of proprietary technology, global service delivery and industry expertise, positions Exela as a leader in enrollments, complex claims processing, appeals and grievance management and payment solutions.
“Our goal has been to set ourselves apart by developing PCH Global as a complete payment integrity solution for the insurance industry, handling everything from claims ingestion and validation, to correspondence, adjudication and payments.”
Should you invest in Exela Technologies shares? Tech stocks offer some of the best growth potential, but time and time again, traders and investors ask us “what are the best tech stocks to buy?” You've probably seen shares of companies such as Amazon and Netflix achieve monumental rises in the past few years, but there are still several tech stocks with room for significant gains. Here is our analysts' view on the best tech stocks to buy right now…